Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
Price Target
Average
766.31%
Revenue Forecast
Estimate
--14.50%
EBIT
Estimate
28.74%
Net Income
Estimate
--10.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Enanta Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ENTA of $65.7 , with forecasts ranging from
a
low of
$54 to a high of $87 .
ENTA Lowest Price Target
Wall Street Target
54 USD
612.40%
ENTA Average Price Target
Wall Street Target
65.7 USD
766.31%
ENTA Highest Price Target
Wall Street Target
87 USD
1047.76%
REVENUE FORECAST
Revenue Forecast Chart ENTA
EBIT FORECAST
EBIT Forecast Chart ENTA
NET INCOME FORECAST
Net Income Chart ENTA